Future in vivo studies would focus on tumour response to treatment and further work would be warranted to decipher the mechanism by which TCEAL1 regulates the cell cycle, thus allowing the development of a more precise approach for combination treatment with docetaxel. Here, TCEAL1 is linked to neoplasm.